Tower Research Capital LLC (Trc) Kodiak Sciences Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.29 Billion
- Q1 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,659 shares of KOD stock, worth $12,806. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,659
Previous 1,709
114.1%
Holding current value
$12,806
Previous $17,000
41.18%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding KOD
# of Institutions
109Shares Held
41.8MCall Options Held
10.9KPut Options Held
700-
Baker Bros. Advisors LP New York, NY17.3MShares$60.6 Million0.58% of portfolio
-
Black Rock Inc. New York, NY3.85MShares$13.5 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.95MShares$6.81 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.69MShares$5.91 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1.33MShares$4.64 Million0.01% of portfolio
About Kodiak Sciences Inc.
- Ticker KOD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,040,200
- Market Cap $182M
- Description
- Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...